1 year return (CAGR)
-16.40%
Rapport Therapeutics, Inc. Common Stock Exchange (NASDAQ, USD)
RAPP
24.21
+1.71 (+7.60%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
1.16B
Price/Sales
58.08
Ent value
1.13B
Price/Book
2.75
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 22.58 |
| Daily high | 25.75 |
| Daily low | 22.58 |
| Daily Volume | 3.09M |
| All-time high | 52.50 |
| 1y analyst estimate | 62.88 |
| Beta | 1.03 |
| EPS (TTM) | -2.89 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 17 Mar 2026 |
Downside potential
Loading...
Downside potential data
| RAPP | S&P500 | |
| Current price drop from All-time high | -53.89% | -1.25% |
| Highest price drop | -75.54% | -56.47% |
| Date of highest drop | 3 Mar 2025 | 9 Mar 2009 |
| Avg drop from high | -27.09% | -10.65% |
| Avg time to new high | 19 days | 12 days |
| Max time to new high | 222 days | 1805 days |
News
